Abstract: Calcium lactate coated psyllium fiber composition and psyllium-containing baked cookie composition having high fiber content and good eating qualities. These baked cookies comprise calcium lactate coated psyllium fiber, insoluble dietary fiber, shortening, flour, sugar and water. Eating quality of these psyllium-containing cookies is especially enhanced by their reduced tendency for the composition to stick to and/or form a film on teeth during ingestion.

Abstract: This invention relates to devices/compositions and methods for treating diseases of the oral cavity in humans and lower animals using non-biodegradable devices/compositions which are biocompatible but not bioerodible for releasing drugs in or around a periodontol pocket or gingival sulcus.

Abstract: The invention relates to a dental filling material containing at least one polymerizable (meth)-acrylic acid ester, characterized in that it contains 20 to 90% by weight, calculated on the total composition, of a compound consisting of the structural element E2 and at least one of the structural elements E1 and/or E3 and/or E4 of the general formula ##STR1## where R.sub.1 denotes a methyl, ethyl, n-propyl, isopropyl or an unsubstituted or CH.sup.3 --C.sub.3 H.sub.7 --substituted phenyl radical, R.sub.2 denotes a CH.sub.2 .dbd.CH--, CH.sub.2 .dbd.CHCOO(CH.sub.2).sub.n --]or ##STR2## or R.sub.1, n denotes 0, 1, 2 or 3, and M denotes titanium or zirconium.

Abstract: Novel antitussive and anesthetic liquid compositions of matter for oral use comprising an effective oral antitussive drug and dyclonine; and method of using same.

Abstract: Disclosed are oral compositions which are effective against calculus comprising a tripolyphosphate salt and an orthophosphate salt.

Abstract: Disclosed are cookies containing psyllium and a method for making those cookies. The cookies may additionally contain polyol polyesters. These cookies provide an effective method for introducing psyllium into the diet to treat gastrointestinal disorders, such as constipation or diarrhea, as well as a method for introducing psyllium and polyol polyesters into the diet to reduce blood cholesterol levels.

Abstract: The present invention relates to sunscreen compositions for substantially daily use containing effective sunscreening agents for both UVA and UVB radiation which are not readily absorbed by the skin; which have increased sunscreen protection and decreased chance for allergy, irritation, or toxicity problems resulting from daily or almost daily use; and which are less susceptible to rub off. These sunscreen compositions provide a constant and even protection against both UVA and UVB radiation and which are cosmetically acceptable. Furthermore, the present invention relates to methods for protecting the skin of humans or lower animals from the effects of UVA and UVB wavelength radiation. This method comprises topically applying to the skin on a substantially daily basis an effective coating of a sunscreen composition of the present invention.

Abstract: The present invention relates to processes for purifying impure psyllium husk using fluorinated hydrocarbons and the psyllium husk having greater than about 99% purity prepared by these processes.

Abstract: Disclosed are oral compositions useful for treating and/or preventing microbial infections in the oral cavity of humans and/or lower animals in need of such treatment comprising a monoperphthalic acid compound and suitable carrier materials having at least 70% of the particle sizes of the latter component(s) in a range of from about 40 microns to 500 microns.

Abstract: This invention relates to compositions/devices and methods for treating diseases of the oral cavity in humans and lower animals using polypropenoic acid compositions/devices for releasing drugs in the oral cavity.

Abstract: Novel volatile silicon compounds are disclosed which are very suitable for use in cosmetic and household products.

Abstract: A mineral supplemented candy product having improved mineral bioavailability properties and which comprises a matrix of sugar-free confectionary ingredients having distributed therein multiple discrete regions of a mineral supplement composition together with multiple discrete regions of a hardboiled candy composition incorporating an edible potentiating agent.

Abstract: Disclosed are stabilizer compositions comprising specific mixed partial salts of a lower alkyl vinyl ether-maleic acid copolymer wherein said partial salts contain as the cationic salt function:(a) from about 10% to about 65% zinc or strontium cations; and(b) from about 10% to about 75% calcium cationsof the total initial carboxyl groups reacted. Also disclosed are denture stabilizing compositions comprising these mixed partial salts, as well as denture stabilizing compositions comprising a safe and adhesively effective amount of two or more denture adhesive components wherein one of said denture adhesive components is the mixed partial salt(s) of the present invention.

Abstract: Disclosed are leave-on facial emulsion compositions that are substantially free from fats and oils and anionic surfactants, which provide improved control of sebum distribution over the surface of the skin. These compositions provide improved cosmetic benefits in terms of the control of the undesirable appearance and tactile sensation of oily skin.

Abstract: Disclosed are leave-on facial emulsion compositions that are substantially free from fats and oils and anionic surfactants, which provide improved control of sebum distribution over the surface of the skin. These compositions provide improved cosmetic benefits in terms of the control of the undesirable appearance and tactile sensation of oily skin.

Abstract: Disclosed are oral compositions containing phosphocitrate to provide improved anticalculus activity.

Abstract: Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a .beta.-aminopropiophenone, such as dyclonine HCl; (b) from about 0.02% to about 20% of saccharin; and (c) from about 1% to about 99% of a pharmaceutically acceptable oral carrier. Also provided are methods for providing an anesthetic effect in humans or animals which comprises orally administering to said human or animal a safe and effective amount of these pharmaceutical compositions. Also provided is a novel process for the manufacture of anesthetic lozenges containing a .beta.-aminopropiophenone along with saccharin.

Abstract: Denture cleansing tablet comprising an inorganic persalt bleaching agent, an organic peroxyacid bleach precursor and a solid base material which in the presence of water releases carbon dioxide with effervescence. The composition provides more rapid and efficaceous denture cleansing performance and anti-bacterial activity.

Abstract: The present invention relates to diagnostic methods for detecting or evaluating the presence of periodontal diseases, especially gingivitis, in humans or lower animals by measuring the presence of leukocyte esterase. These diagnostic methods comprise measuring the amount of leukocyte esterase present in the oral cavity of the human or lower aniaml being diagnosed.The present invention further relates to diagnostic products useful in vivo for detecting or evaluating the presence of periodontal diseases, especially gingivitis, in humans. These diagnostic products contain at least one agent useful in detecting the presence of leukocyte esterase, and a carrier material. These diagnostic products must be sterile and safe for in vivo contact with the tissue in the oral cavity of the human being diagnosed.Finally, the present invention further relates to diagnostic kits useful for detecting or evaluating the presence of periodontal diseases, especially gingivitis, in humans.

Abstract: Processes for selectively comminuting impure psyllium seed husk. These processes comprise milling impure psyllium seed husk in a mill which causes the husk to be fragmented by collision under conditions whereby the mean particle size of the husk material is reduced relatively more than the mean particle size of the non-husk material. In addition, processes for purifying selectively comminuted psyllium seed husk are described.